Regeneron
New York, NY – December 3, 2025 – In a significant move reverberating through the biotechnology sector, investment banking giant Morgan Stanley has downgraded Regeneron Pharmaceuticals (NASDAQ: REGN) from "Overweight" to "Equal-Weight." The firm maintained its price target of $767.00, signaling that, in their view, the stock
AT&T
New York, NY – October 23, 2025 – Royal Bank of Canada (RBC) Capital has recalibrated its outlook for telecommunications giant AT&T (NYSE: T), lowering its price target while maintaining an "Outperform" rating. This adjustment, coming on the heels of AT&T's mixed third-quarter 2025
Tourmaline Oil
Calgary, AB – October 22, 2025 – Tourmaline Oil Corp. (OTCMKTS:TRMLF), a prominent player in the Canadian oil and gas sector, has seen its stock rating lowered by Zacks Research, shifting from a "hold" to a "strong sell." This significant downgrade, effective on or around October 22,
Freeport-McMoRan
NEW YORK, NY – October 9, 2025 – Freedom Capital Markets has today downgraded the stock of copper mining giant Freeport-McMoRan (NYSE: FCX) from a 'Buy' to a 'Hold' rating, simultaneously slashing its price target from $55.00 to $47.00. This significant shift in analyst sentiment comes
KB Home
Evercore ISI Cuts Rating as Homebuilder Grapples with Demand and Affordability Challenges KB Home (NYSE: KBH), one of the nation's prominent homebuilders, is currently navigating a period of heightened scrutiny, with its stock facing significant downgrades from leading financial analysts. On October 7, 2025, Evercore ISI Group notably
KB Home
Los Angeles, CA – October 7, 2025 – KB Home (NYSE: KBH), a prominent player in the U.S. homebuilding industry, is currently facing significant investor scrutiny following a series of stock downgrades from leading analyst firms. The latest adjustment occurred today, October 7, 2025, when Evercore ISI Group moved KB Home&